DNA SEQUENCES, VECTORS, AND FUSION POLYPEPTIDES TO INCREASE SECRETION OF DESIRED POLYPEPTIDES FROM FILAMENTOUS FUNGI

Abstract: The invention includes novel fusion DNA sequences encoding fusion polypeptides which when expressed in a filamentous fungus result in increased levels of secretion of the desired polypeptide as compared to the expression and secretion of such polypeptides from filamentous fungi transformed with previously used DNA sequences. The fusion DNA sequences encode a fusion polypeptide comprising, from the amino to carboxyl-terminus, first, second, third and fourth amino acid sequences. The first DNA sequence encodes a signal peptide functional as a secretory sequence in a first filamentous fungus. The second DNA sequence encodes a secreted polypeptide or portion thereof which is normally secreted from the same filamentous fungus or a second filamentous fungus. The third DNA sequence encodes a cleavable linker polypeptide while the fourth DNA sequence encodes a desired polypeptide.

Description: DNA SEQUENCES, VECTORS, AND FUSION POLYPEPTIDES TO INCREASE SECRETION OF DESIRED POLYPEPTIDES FROM FILAMENTOUS FUNGI Background of the Invention This is a continuation-in-part of United States Patent Application Serial No. 07/163,219, filed February 26, 1988 which is a continuation of United States Patent Application Serial No. 06/882,224, filed July 7, 1986, now abandoned, which is a continuation-in-part of United States Patent Application Serial No. 06/771,374, filed August 29, 1985. TECHNICAL FIELD OF THE INVENTION The present invention is directed to increased secretion of desired polypeptides from filamentous fungi. The invention discloses DNA sequences, vectors, fusion polypeptides, and processes for obtaining enhanced production and secretion levels of the desired polypeptide. More particularly, the invention discloses DNA sequences, vectors, fusion polypeptides and processes for the increased secretion of bovine chymosin from filamentous fungi. BACKGROUND OF THE INVENTION One of the earlier successes of recombinant DNA technology involved the intracellular expression of the A and B chains of insulin in bacteria aε carboxyl fusions to β-galactosidase. Goeddel, D.V. et al. (1979); Proc. Natl. Acad. Sci. USA 76. 106-110; Johnson, I.S. (1983) Science 219. 632-637. Since then, numerous examples have been described for the expression of fusion polypeptides comprising, in part, a heterologous polypeptide. Marston, F.A.O. (1986) Biochem. J. 240. 1-12 summarizes the production of heterologous polypeptides in E.coli. As described therein, a number of heterologous polypeptides have been expressed intracellularly as fusion polypeptide in E. coli. In addition, heterologous polypeptides have reportedly been secreted into the periplasmic space of such microbes by fusing the heterologous polypeptide with a signal sequence. In some cases, the heterologous polypeptide was secreted from E. coli into the culture medium when expressed with a signal sequence of bacterial origin. In those cases where a heterologous protein has been expressed as a fusion with the entire native protein of the host bacteria, the rational was primarily to increase stability or ease the purification of the fusion polypeptide. For example, Scholtissek, S. et s . (1988) Gene 62 55-64, report the expression in ____ coli of a triprotein consisting of bacterial ø-galactosidase, a collagenase recognition site and the single stranded DNA binding protein from _____ coli. The β - galactosidase portion of this fusion polypeptide reportedly was used to purify the fusion polypeptide from a crude cell lysate by affinity chromatography on APTG-Sepharose. The single stranded DNA binding protein from ____ coli was thereafter isolated from the fusion polypeptide by reacting the collagenase recognition site with collagenase. Similarly, Smith, D.B. __t __1. (1988) Gene 67. 31-40 report the bacterial expression of a vector encoding a fusion polypeptide consisting of glutathione S-transferase fused at its C-terminus with a recognition site for blood coagulation factor X a which itself is fused to either of two heterologous polypeptides corresponding to different antigens of 2__ falciparum. In another example, Guan, C. ____ _al. (1988) Gene 67. 21-30 report the expression and purification of fusion polypeptides consisting of maltose binding protein fused either to β-galactosidase or PstI Endonuclease, and a fusion protein consisting of the bacterial phoA signal, maltose binding protein and phoA protein. In the former cases, the fusion polypeptides were extracted from crude bacterial lysates by affinity chromatography on cross-linked amylose whereas, in the latter, the fusion protein was obtained from the periplasmic space after εpheroplast formation and affinity chromatography on cross-linked amylose. The expression of fusion polypeptides in yeast has also been reported. For example, Cousens, L.S. et al. (1987) Gene 61. 265-275, describe a fusion polypeptide consisting of a human superoxide dismutase-human proinsulin fusion protein with a ethionine residue at the junction of the two proteins. Superoxide dismutase is an intracellular protein and the fusion polypeptide was reportedly expressed as an insoluble inclusion body within the yeast expression host with incorrect disulfide bonds. After εulfitollysis proinsulin was reportedly purified, renatured and processed to yield insulin after cleavage of the methionine residue with cyanogen bromide. United States Patent No. 4,751,180 to Cousens et al. states that a polypeptide of interest may be obtained in high yield from an expression host, such as yeast, when the polypeptide of interest is expressed as a completely heterologous fusion polypeptide. One of the heterologous polypeptides is produced in high yield in the expression host typically in amounts greater than five percent of the total protein produced by the host. The only high yield heterologous polypeptide disclosed, however, is that of the intracellular protein human superoxide diεmutase which is fuεed to either proinεulin or IgF- 2. The specification also states that a secretory leader and procesεing signal may be included as part of the fuεed polypeptide. No example is provided which indicates that secretion would be obtained and, if obtained, would be at levels higher than that which have been obtained using a fusion construction which detected the high yield heterologous protein in a fusion consisting of a secretory leader sequence fuεed to only the polypeptide of intereεt, e.g. proinsulin or insulin-like growth factor (IgF-2). Heterologous gene expression has also been reported in filamentous fungi. For example, Christensen, T. S ~ _χ. (1988) Bio/Technoloσv §_, 1419-1422 have reported an expresεion vector utilizing the α-amylase promotor from ____ oryzae to express the prepro form of aspartyl proteinase from the filamentous fungus Rhizomuchor miehei. When expressed in ____ oryzae. aspartyl proteinase was obtained from the culture medium. When Gwynne, D.I. et g_ . (1987) Bio/Technolocrv 5 , 713-719, report the expression and secretion of human interferon and bacterial endoglucanase from filamentous fungi by expressing these genes with either a fungal glucoamylase signal or a synthetic consensus signal sequence. Upshall, A. et al. (1987) Bio/Technology 5_, 1301-1304 report the expression and secretion of human tissue plas inogen activator by expressing the gene encoding the pre-for of t-PA in a filamentous fungus. Further, Turnbull, I.F. ____ al. (1989) Bio/Technology 2 . 169-174 report an attempt to expresε and secrete bacterial enterotoxin subunit . B from filamentous fungi. No secreted material, however, was detected. Bovine prochymosin haε reportedly been expressed in Escherichia coli. the yeasts Saccharomvces cerevisiae and Yarrowia lipolvtica. and in filamentous fungi by the inventor in Aspergillus species. In __. coli prochymosin, with the first four amino acid residues replaced by an amino-teπninal fragment of the troE gene, has reportedly been produced under the control of the trp promoter (Nishimori, K. et al * (1984) Gene 29 _ 41-49). The fusion protein accumulated as inclusion bodies in the cytoplasm but after appropriate extraction conditions could be activated to yield mature chymosin. Moir _gjt al. (1985) (Ins Developments in Industrial Microbiology. Vol. 26. Underkofler, L.A. (ed.). Society for Industrial Microbiology, Arlington, VA, U.S.A.) described intracellular production of prochymosin in S_. cerevisiae. The protein was synthesized with various segments of phosphoglycerate kinase, trioεephoεphate isomerase or galactokinase attached to the amino terminus, allowing increased production compared to direct expression from the εa e promoterε. It waε suggested that the increase in production was due to more efficient translation of the mRNA. Moir ____ al. also reported secretion of prochymosin from J5. cerevisiae. in the form of a fusion with the first few residues of invertase or alpha factor. The extracellular prochymosin was activated at low pH to give mature chymosin despite the additional amino acids on the prosequence. Similarly, activatable prochymoεin waε secreted from the yeast Y. lipolvtica with either 14 or 90 residueε of native alkaline extracellular protease attached to the amino terminus (Franke, A.E. et al * (1988) In: Developments in Industrial Microbiology. Vol. 29. Pierce, G. (ed.) . Society for Industrial Microbiology, Arlington, VA, U.S.A.). In this report, no more than about 20% of the amino terminuε of the protease was used to generate the fusion polypeptides and no apparent advantage accrued from expression as fusion polypeptides. Active calf chymosin has also been produced in the fila entouε funguε Trichoder a reesei (Harkki, A. et al * (1989) Bio/Technology X, 596-603. The cellobiohydrolase I gene (cbhl) promoter and terminator regionε were employed and four different constructions were made employing different signal sequences fused to prochymosin cDNA. Either the chymosin signal sequence, cbhl signal sequence, a hybrid cbhl/chymosin signal sequence or the cbhl signal sequence plus 20 amino acids of mature cbhl were fused to the amino terminus of prochymosin. Slightly better production was obtained from the latter construction although insufficient numbers of transformants were examined to confirm this. Secretion was inefficient with approximately 66% of the chymosin-derived material remaining within the cell of tranεformantε regardless of the type of vector construction uεed. The glaA gene encodeε glucoamylaεe which is highly expreεεed in many strains of Asperoillus niαer and Aspergillus awa ori. The promoter and secretion signal sequence of the αlaA gene have been used to express heterologous genes in Aspergilli including bovine chymosin in Aspergillus nidulans and A.. awamori as previously described by the inventors (Cullen, D. a al * (1987) Bio/Technolocrv £, 713-719) and EPO Publication No. 0 215 * 594). In the latter experimentε, a variety of conεtructs were made, incorporating prochymosin cDNA, either the glucoamylase or the chymosin secretion signal and, in one case, the first 11 codons of mature glucoamylaεe. Maximum yieldε of secreted chymosin obtained from &. awamori were below 15 mg/1 in 50 ml shake flask cultures and were obtained using the chymosin signal sequence encoded by pGRG3. These previous studies indicated that integrated plasmid copy number did not correlate with chymosin yields, abundant polyadenylated chymosin mRNA waε produced, and intracellular levelε of chymoεin were high in εome tranεformants regardless of the source of secretion signal. It was inferred that transcription was not a limiting factor in chymosin production but that secretion may have been inefficient. It was also evident that the addition of a small amino terminal segment (11 amino acids) of glucoamylase to the propeptide of prochymosin did not prevent activation to mature chymosin. The amount of extracellular chymosin obtained with the first eleven codons of glucoamylase, however, was substantially less than that obtained when the glucoamylase signal waε uεed alone. Accordingly, an object of the invention herein is to provide for the expreεεion and enhanced secretion of desired polypeptides by and from filamentous fungi including fusion DNA sequences, expresεion vectors containing εuch DNA sequences, transformed filamentous fungi, fusion polypeptides and procesεes for expressing and secreting high levels of such desired polypeptides. It is a further object of the invention to provide for the expression and enhanced secretion of chymosin from filamentous fungi including fusion DNA εequenceε, vectors containing such DNA sequences transformed filamentous fungi, fusion chymosin polypeptides and processes for expressing and secreting high levelε for chymoεin. The references discuεεed above are provided εolely for their diεclosure prior to the filing date of the instant case. Nothing herein is to be construed as an admisεion that the inventorε are not entitled to antedate such discloεure by virtue of prior invention or priority baεed on earlier filed applicationε. SUMMARY OF THE INVENTION In accordance with the above objectε, the invention includes novel fusion DNA sequences encoding fusion polypeptides which when expressed in a filamentous fungus result in the expression of fusion polypeptides which when secreted result in increased levels of secretion of the desired polypeptide as compared to the expresεion and secretion of such polypeptides from filamentous fungi transformed with previously used DNA seguenceε. The fusion DNA sequences comprise from the 5' terminuε four DNA sequences which encode a fusion polypeptide comprising, from the amino to carbonyl- terminus, first, second, third and fourth amino acid sequences. The first DNA sequence encodes a signal peptide functional as a secretory sequence in a first filamentous fungus. The second DNA sequence encodes a secreted polypeptide or portion thereof which is normally secreted from the same filamentous fungus or a second filamentous fungus. The third DNA sequence encodes a cleavable linker polypeptide while the fourth DNA sequence encodes a -desired polypeptide. When the fuεion DNA εequence iε expreεεed either in the first or second filamentous fungus, increased εecretion of the deεired polypeptide iε obtained -aε compared to that which iε obtained when the deεired polypeptide is expressed from DNA sequences encoding a fusion polypeptide which does not contain the second polypeptide normally secreted from either of the filamentous fungi. The invention also includeε expreεεion vectors containing the above fusion DNA sequence and filamentous fungi transformed with such expresεion vectorε. The invention also includes the fusion polypeptide encoded by such fuεion DNA sequences. Further, the invention includes a process for producing a desired polypeptide comprising transforming a host filamentous fungus with the above described expression vector and culturing the host filamentous fungus to secrete the desired polypeptide into the culture medium. BRIEF DESCRIPTION OF THE DRAWINGS FIG. l depicts the construction of pBRΔgam-arg. FIG. 2 depictε the diεruption of the glaA gene by replacement of the 5.5 kb DNA chromosomal fragment with a 4.5 kb fragment from pBRΔgam-argB. FIGS. 3A and 3B depict the construction of pGRG(l-4). FIGS. 4, 4A, 4B, 4C and 4D depict the various casεette inserts used to generate pGRGl through pGRG4. FIGS. 5, 5A and 5B depict the conεtruction of pGAMpR. FIG. 6 depictε the construction of pUCAMpRl. FIG. 7 depicts the construction of pSGl. FIG. 8 depicts Southern blot analysis of DNA from transformants of εtrainε GC12 and GCΔGAMpR. FIG. 9 depicts Northern blot analysis of RNA from strain GC12 and transformants 12grgl-la and 12gampr . FIG. 10 depicts products of in vitro translation of RNA from strain GC12 and transformantε 12grgl-la and 12gampr4. FIG. 11 depicts Western analysis of chymosin in culture supernatants of tranεformantε 12grgl-la and 12gampr4. DETAILED DESCRIPTION The inventors have discovered that desired polypeptides can be expressed and secreted at levels higher than that previously obtained by fusing the deεired polypeptide with a polypeptide which iε normally secreted from a filamentous fungus. Previously, the inventors discovered that heterologous polypeptides such as bovine chymosin and glucoamylaεe and carboxyl (= aspartyl) protease from filamentouε fungi could be expreεεed and secreted from Aspergillus species as described in the parent applications and EPO Publication No. 0 215 594, each of which are expresεly incorporated herein by reference. For example, the inventorε previouεly achieved expreεεion and εecretion of bovine chymoεin from Aspergillus nidulans at levels approaching 1.5 micrograms per ml of medium when expressed as a fusion between the glucoamylase signal peptide and the pro-form of chymosin. The vector encoding thiε particular construction iε deεignated pGRGl (εee FIGS. 3 and 4A) . However, when the glucoamylaεe signal peptide together with the glucoamylase propeptide and the first eleven amino acids of glucoamylase were fused to prochymosin, secretion levels were subεtantially reduced to about half of the term obtained in the previouε construction, i.e. reduced to approximately 0.75 μg per ml of medium. This vector was previously identified as pGRG4 and is identified in Fig. 3 and 4D. All of the plasmids pGRGl, pGRG3 and pGRG4 (see FIG. 3 and 4A, B, C and D) have been transformed into ____ awamori. The tranεformant which produced the greateεt amount of extracellular chymosin was obtained using pGRG3. With improvements to culture medium and conditions the higheεt level of εecreted chymoεin obtained waε below 15 μg/mL aε meaεured by enzyme immunoaεsay (which will detect inactive and degraged chymosin in addition to mature chymosin) . By using the fusion DNA constructionε described herein, a dramatic increase in extracellular chymosin has been obtained. In some cases chymoεin levels are approximately 20 fold in excess of that obtained previously. Commensurate with this increase in εecretion iε the reduction in the amount of chymosin maintained intracellularly in the filamentouε fungi expreεεion host. Well over 50% and, in some cases, as much as almost 98% of the chymosin produced previouεly waε maintained intracellularly (εee Table II) . When the vectorε encoding the DNA εequenceε of the invention herein were uεed, however, thirty percent or less, and in some caεeε, less than 1% of the chymosin expreεsed was maintained intra¬ cellularly. The increased secretion levelε of chymoεin are the result of expressing chymosin in its pro-form as a fusion polypeptide with a polypeptide normally secreted by a filamentous funguε. In the preferred embodimentε, glucoamylaεe from &__. awamori encoded by the glaA gene, including the secretory signal sequence of glucoamylase is fused to the amino- terminuε of prochymoεin. The preεence of the glucoamylaεe signal sequence and mature glucoamylase peptide sequences facilitate the enhanced secretion of the fusion polypeptide into the culture medium. Mature chymosin iε then obtained by acidifying the medium to proceεε the chymosin prosequence to produce active chymosin by removal of the propeptide. Aε used herein, a "fusion DNA sequence" compriseε from 5' to 3' firεt, second, third and fourth DNA sequences. The "first DNA sequence" encodes a signal peptide functional as a secretory sequence in a first filamentous fungus. Such signal sequences include those from glucoamylase, o-amylaεe and aεpartyl proteases from Aspergillus awamori. Aspergillus niger. Aspergilluε oryzae. signal sequences from eel1obiohydrolaεe I, cellobiohydrolase II, endoglucanase I, endoglucanaεe III from Trichoderma. signal sequences from glucoamylaεe from Neurosoora and Humicola as well as signal sequenceε from eukaryoteε including the εignal sequence from bovine chymosin, human tisεue plasminogen activator, human interferon and synthetic consensus eukaryotic signal εequenceε εuch as that described by Gwynne (1987) supra. Particularly preferred signal sequences are those derived from polypeptides secreted by the expression host used to express and secrete the fusion polypeptide. For example, the signal sequence from glucoamylase from Aspergillus awamori is preferred when expresεing and εecreting a fuεion polypeptide from Aεpergillus awamori. As used herein, firεt amino acid sequences correspond to secretory sequences which are functional in a filamentous fungus. Such amino acid sequences are encoded by first DNA sequences as defined. Aε used herein, "second DNA sequences" encode "secreted polypeptides" normally expressed from filamentous fungi. Such secreted polypeptides include glucoamylase, α-amylase and aspartyl proteases from Aspergillus awamori. Aspergillus niger. and Aspergillus orvzae. cellobiohydrolase I, cellobiohydrolase II, endoglucanase I and endoglucanase III from Trichoderma and glucoamylase fro Neuroεpora εpecies and Humicola species. As with the first DNA sequences, preferred secreted polypeptides are thoεe which are naturally secreted by the filamentous fungal expression host. Thuε, for example when uεing Aεoergillus awamori. preferred secreted polypeptides are glucoamylase and α-amylase from Aspergillus awamori . most preferably glucoamylaεe. Aε uεed herein, "third DNA sequences" comprise DNA sequences encoding a cleavable linker polypeptide. Such sequenceε include thoεe which encode the proεequence of bovine chymoεin, the proεequence of subtilisin, prosequenceε of retrovirul proteases including human immunodeficiency virus protease and DNA sequences encoding amino acid sequenceε recognized and cleaved by trypsin, factor X a collagenase, clostripin, subtilisin, chymoεin, yeaεt KEX2 proteaεe and the like. See e.g. Marεton, F.A.O. (1986) Biol. Chem J. 240. 1-12. Such third DNA εequences may also encode the amino acid methionine which may be selectively cleaved by cyanogen bromide. It should be underεtood that the third DNA εequence need only encode that amino acid εequence which iε neceεεary to be recognized by a particular enzyme or chemical agent to bring about cleavage of the fusion polypeptide. Thus, the entire proεequence of, for example, chymosin or subtilisin need not be used. Rather, only that portion of the prosequence which iε necessary for recognition and cleavage by the appropriate enzyme is required. As used herein, "fourth DNA sequences" encode "desired polypeptides." Such desired polypeptides include mammalian enzymes such as bovine chymosin, human tisεue plaεminogen activator etc. , mammalian hormoneε εuch as human growth hormone, human interferon, human interleukin and mammalian proteins εuch as human serum albumin. Desired polypeptides also induce bacterial enzymes such as α-amylase from Bacillus species, lipase from Pseudomonas species, etc. Desired polypeptides further include fungal enzymes such as lignin peroxidase and Mn 2+ -dependent peroxidase from Phanerochaete. glucoamylase from Humicola species and aspartyl proteases from Mucor species. The above-defined four DNA sequenceε encoding the correεponding four amino acid sequences are combined to form a "fusion DNA sequence." Such fusion DNA εequenceε are assembled in proper reading frame from the 5' terminus to 3' terminuε in the order of firεt, second, third and fourth DNA sequences. As so assembled, the DNA sequence will encode a "fusion polypeptide" encoding from its amino-terminus a signal peptide functional as a secretory sequence in a filamentous fungus, a secreted polypeptide or portion thereof normally secreted from a filamentous fungus, a cleavable linker polypeptide and a desired polypeptide. As indicated, the first DNA sequence encodes a signal peptide functional as a secretory signal in a first filamentous fungus. The signal sequences may be derived from a secreted polypeptide from a particular species of filamentous fungus. As also indicated, the second DNA sequence encodes a second amino acid sequence corresponding to all or part of a polypeptide normally secreted by either the first filamentous fungus (from which the signal peptide is obtained) or a second filamentous fungus (if the signal peptide and secreted polypeptide are from different filamentous fungi or if the signal peptide is obtained from a source other than a filamentous fungus, e.g. the chymosin εignal from bovine species) . As indicated, all or part of the mature sequence of the secreted polypeptide is used in the construction of the fusion DNA sequences. It is preferred that full length secreted polypeptides be used to practice the invention. However, functional portionε of the secreted polypeptide may be employed. As uεed herein a "portion" of a εecreted polypeptide iε defined functionally as that portion of a secreted polypeptide which when combined with the other components of the fusion polypeptide defined herein results in increased secretion of the desired polypeptide as compared to the level of desired polypeptide secreted when an expression vector is used which does not utilize the secreted polypeptide. Thus, the secretion level of a fusion DNA sequence encoding first, second, third and fourth amino acid sequences (the second DNA εequence containing all or a portion of a εecreted polypeptide) is compared to the secretion level for a second fusion polypeptide containing only first, third and fourth amino acid sequences (i.e., without a secreted polypeptide or a portion thereof) . Those amino acid sequences from the secreted polypeptide, and DNA sequences encoding such amino acids, which are capable of producing increaεed secretion as compared to the second fusion polypeptide comprise the "portion" of the secreted polypeptide aε defined herein. Generally, such portions of the secreted polypeptide comprise greater than 50% of the secreted polypeptide, preferably greater than 75%, most preferably greater than 90% of the secreted polypeptide. Such portions compriεe preferably the amino-terminal portion of the secreted polypeptide. The "filamentous fungi" of the present invention are eukaryotic microorganisms and include all filamentous formε of the subdivision Eumycotina, Alexopoulos, C.J. (1962), Introductory Mycology. New York: Wiley. These fungi are characterized by a vegetative mycelium with a cell wall composed of chitin, cellulose, and other complex polysaccharides. The filamentouε fungi of the preεent invention are morphologically, phyεiologically, and genetically diεtinct from yeaεtε. Vegetative growth by filamentouε fungi is by hyphal elongation and carbon catabolis iε obligately aerobic. In contraεt, vegetative growth by yeaεtε such as S. cerevisiae is by budding of a unicellular thallus, and carbon catabolism may be fermentative. S. cerevisiae has a prominent, very stable diploid phase whereas, diploids exist only briefly prior to meiosiε in filamentous fungi like Aspergilli and Neurospora. S. cervisiae has 17 chromosomeε aε oppoεed to 8 and 7 for ____ nidulans and N. crassa respectively. Recent illustrations of differences between S. cereviεiae and filamentous fungi include the inability of ____ cerevisiae to process Aεpergillus and Trichoderma introns and the inability to recognize many transcriptional regulators of filamentous fungi (Innis, M.A. et al. (1985) Science. 228. 21-26). Variouε species of filamentous fungi may be used as expreεεion hosts including the following genera: Aspergillus. Trichoderma. Neurospora. Penicillium. Cephalosporium. Achlya. Podospora. Endothia. Mucor. Cochliobolus and Pyricularia. Specific expression hosts include A. nidulans. (Yelton, M. , et al. (1984) Proc. Natl. Acad. Sci. USA. 81. 1470-1474; Mullaney, E.J. et al * (1985) Mol. Gen. Genet. 199. 37-45; John, M.A. and J.F. Peberdy (1984) Enzyme Microb. Technol. 6 , 386-389; Tilburn, et al. (1982) Gene 26. 205-221; Ballance, D.J. et al.. (1983) Biochem. Biophys. Res. Comm. 112. 284-289; Johnston, I.L. e£ al. (1985) EMBO J. , 1307-1311) A. niger. (Kelly, J.M. and M.Hynes (1985) EMBO __, 475-479) __. awamori. e.g., NRRL 3112, ATCC 22342, ATCC 44733, ATCC 14331 and εtrain UVK 143f, _ . orvzae. e.g., ATCC 11490, N. crassa (Case, M.E. et al. (1979) Proc. Natl. Acad. Scie. USA 76. 5259-5263; Lambowitz U.S. Patent No. 4,486,553; Kinsey, J.A. and J.A. Rambosek (1984) Molecular and Cellular Biology 4., 117-122; Bull, J.H. and J.C. Wooton (1984) Nature 310. 701-704), Trichoderma reesei. e.g. NRRL 15709, ATCC 13631, 56764, 56765, 56466, 56767, and Trichoderma vjride. e.g., ATCC 32098 and 32086. A preferred expression host is ____ awamori in which the gene encoding the major secreted aspartyl protease has been deleted. The production of this preferred expression host is deεcribed in United Stateε Patent Application Serial No. 214,237 filed July 1, 1988, expreεεly incorporated herein by reference. Aε uεed herein, a "promotor sequence" is a DNA εequence which is recognized by the particular filamentous fungus for expression purposes. It is operably linked to a DNA sequence encoding the above defined fusion polypeptide. Such linkage comprises positioning of the promoter with reεpect to the tranεlation initiation codon of the DNA sequence encoding the fusion DNA sequence. The promoter sequence contains transcription and translation control sequences which mediate the expression of the fusion DNA sequence. Examples include the promoter from the ____ awamori or A. niger glucoamylase genes (Nunberg, J.H. et al. (1984) Mol. Cell. Biol. ±, 2306-2315; Boel, E. et al. (1984) EMBO J. 2, 1581- 1585) , the Mucor miehei carboxyl protease gene herein, the Trichoderma reesei cellobiohydrolase I gene (Shoemaker, S.P. at &1 * (1984) European Patent Application No. EPO0137280A1) , the ____ nidulans trpC gene (Yelton, M. ____ al * (1984) Proc. Natl. Acad. Sci. USA » 1470-1474; Mullaney, E.J. et al * (1985) Mol. Gen. Genet. 199. 37-45) the __ nidulans alcA gene (Lockington, R.A. at al. (1986) Gene 1, 137-149) , the _\__ nidulans tpiA gene (McKnight, G.L. __t al. (1986) Cell 6., 143-147), the ____ nidulans amdS gene (Hynes, M.J. et al. (1983) Mol. Cell Biol. 2, 1430- 1439) , and higher eukaryotic promoters such as the SV40 early promoter (Barclay, S.L. and E. Meller (1983) Molecular and Cellular Biology 3. 2117-2130). Likewise a "terminator sequence" is a DNA sequence which is recognized by the expresεion hoεt to terminate transcription. It is operably linked to the 3' end of the fusion DNA encoding the fusion polypeptide to be expressed. Examples include the terminator from the A. nidulans trpC gene (Yelton, M. a al * (1984) Proc. Natl. Acad. Sci. USA 81. 1470- 1474; Mullaney, E.J. at al * (1985) Mol. Gen. Genet. 199. 37-45) , the &__, awamori or A. niger glucoamylase genes (Nunberg, J.H. et al. (1984) Mol. Cell. Biol. , 2306-253; Boel, E. et al. (1984) EMBO ____ 3, 1581- 15851 , and the Mucor miehei carboxyl proteaεe gene (EPO Publication No. 0 215 594), although any fungal terminator iε likely to be functional in the preεent invention. A "polyadenylation sequence" is a DNA sequence which when transcribed is recognized by the expreεsion host to add polyadenoεine reεidueε to tranεcribed mRNA. It iε operably linked to the 3' end of the fuεion DNA encoding the fusion polypeptide to be expressed. Examples include polyadenylation sequences from the A. nidulans trpC gene (Yelton, M. ____ al * (1984) Proc. Natl. Acad. Sci. USA 81. 1470-1474; Mullaney, E.J. et al * (1985) Mol. Gen. Genet. 199. 37-45) , the ____ awamori or A. niger glucoamylase geneε (Nunberg, J.H. et al * (1984) Mol. Cell. Biol. 4, 2306-2315) (Boel, E. et al * (1984) EMBO J. 2, 1581-1585), and the Mucor miehei carboxyl protease gene described above. Any fungal polyadenylation sequence, however, is likely to be functional in the present invention. MATERIALS AND METHODS General methodε were aε previously described in EPO Publication 0 215 594. Strains The Aspergillus awamori strains used in this work were all derived from a glucoamylaεe over-producing εtrain (UVK143f) , itself derived from NRRL3112 as described in EPO Publication No. 0 215 594. Strain genotypes were: strain GC12 (pγrG5; aroB3) (derived from strain pyr4-5, also known as GC5, as described in United States Patent Application Serial No. 214,237) and strain GCΔGAM23 royrG5: ΔglaA23i. Strain GCΔGAM23 was derived from strain GC12 by disruption of the glucoamylase (glaA) gene. This was achieved by transformation with a linear DNA fragment (similar to the method described by Miller et al. (1985) Mol. Cell. Biol. 5, 1714-1721) having glaA flanking sequences at either end and with 2.7 kb of the promoter and coding region of the αlaA gene replaced by the Aεperαilluε nidulanε argB gene aε selectable marker. The vector from which we obtained this linear fragment of DNA was assembled aε follows (Fig. 1). A 5.5 kb Clal fragment of DNA containing approximately 3.5 kb of 5' flanking DNA and approximately 2 kb of coding sequence of the __. awamori UVK143f glaA gene was cloned into the Clal site of pBR322. Thiε plasmid was cut with reεtriction endonucleaεeε Xhol and Bglll to remove a section of DNA extending from a position 1966 bp upεtream from the translation start codon to' a position following approximately 200 codons of coding sequence. The overhanging DNA ends were filled in using the Klenow fragment of DNA polymerase I and ligated -to reconstitute a Bglll cleavage site and give pBRΔGAMXB. A 1.7 kb BamHI fragment containing the Aεperαilluε nidulans argB gene was cloned into this reconstituted Bglll site to create the vector pBRΔgam-argB4 shown in Fig. 1. This vector was cut with Clal and used to transform strain GC12 using complementation of the argB mutation to select for tranεformantε. Integration of the linear fragment containing the glaA flanking sequences and the argB gene at the chromosomal glaA locus was identified by Southern blot analysis. Briefly, DNA from transformants and strain GC12 was digeεted with Clal. subjected to agarose gel electrophoreεiε, tranεferred to a membrane filter and hybridized with a radiolabelled fragment of DNA containing the A., niger αlaA gene. Two bands (5.5 and 1.9 kb in size) were observed in untransformed GC12 DNA following autoradiography repreεenting the chromoεomal αlaA gene (data not shown) . The predicted alteration due to disruption of the αlaA gene was replacement of the 5.5 kb DNA fragment with a fragment of 4.5 kb (Fig. 2 ) . Thiε change had occurred in tranεformed strain GCΔ GAM23 . Enzyme immunoassays specif ic for glucoamylase confirmed that thiε strain did not secrete detectable levelε of glucoamylaεe. Media Aspergillus complete and minimal media (Rowlands, R.T. et al. (1973) Mol. Gen. Genet. 126. 201-216) were uεed for the growth of fungal colonieε and were supplemented with 2mg/ml arginine or uridine as required. Two different liquid media were used to study chymoεin production in. shake flaεkε. SCM conεiεted of maltoεe, 50 g/1; malt extract, 20 g/1; yeaεt extract, 5 g/1; bacto-peptone, 1 g/1; arginine, 1 g/1; uridine, 1 g/1; methionine, 0.5 g/1; biotin, 2 mg/1; εtreptomycin, 50 mg/1; KH2PO , 34 g/1; NaNθ3, 6 g/1; MgS0 4 .7H 2 0, 1 g/1; KCl, 0.52 g/1; trace elements solution (18), 1 ml/1; Tween-80, 1 ml/1; Mazu DF60-P antifoam (Mazur chemicals Inc.), 2 ml/1; pH5. Soy medium contained maltose, 150 g/1; soy bean meal or εoluble εoy-milk powder, 60 g/1; sodium citrate, 70 • g/1; (NH ) 2 S0 4 , 15 g/1; NaH 2 P0 4 , 1 g/1; MgS0 , 1 g/1; Tween-80, 1 ml/1; Mazu DF60-P antifoam 2 ml/1; arginine 1 g/1; uridine, 1 g/1; streptomycin 50 mg/1; pH 6.2. Fungal tranεformation Polyethylene glycol (PEG) mediated tranεformation waε performed aε deεcribed previously Cullen, D. et al. (1987) Bio/Technology £, 369-376 except that 0.7 M KCl was used during preparation of protoplasts and was also added to the PEG εolution. In addition, aurintricarboxylic acid (10μg/ml) was added to the final protoplaεt waεh prior to PEG treatment. We have obεerved that thiε nucleaεe inhibitor increaεed tranεformation frequencieε for A. awamori by 2-5 fold and had little effect on protoplaεt viability (data not εhown) . Transformation by electroporation was performed aε deεcribed by Ward §__, al (1988) Curr. Genet. 14. 37- 42. Briefly, washed protoplasts were suspended in electroporation buffer (7 mM sodium phosphate, pH 7.2, 1 mM MgS0 4 , 1.4 M sorbitol), DNA was added and a pulse of 2,125 V/cm was delivered from the 25 μFD capacitor of a Bio-Rad Gene Pulser apparatus. Following either method of transformation protoplaεtε were plated onto solidified Aspergilluε minimal medium with 1.2 M sorbitol and lacking uridine. DNA and RNA manipulation Standard methods were uεed for plaεmid isolation, restriction enzyme digestion, ligation of DNA, DNA fragment isolation, DNA dephosphorylation, nick translation and Southern analysiε (Maniatis, T. et al (1982) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York) . Fungal DNA was isolated aε previously described (Cullen, D. et al (1982) Bio/Technology __, 369-376) . Total RNA was extracted from fungi (24) and poly(A) + RNA was selected on oligo(dT) columns by standard procedures Maniatis (1982) supra. RNA was electrophoresed in formaldehyde-agarose gels prior to blotting to membrane filters for Northern analysis (UL.)* In vitro translation n vitro translation of poly(A) + RNA from A., awamori waε done uεing rabbit reticulocyte lyεateε (Betheεda Research Laboratories, Gaithersberg, MD) . Each 60 μl reaction contained the following: 2.6 μl 2M potaεεium acetate, pH 7.2, 3 μl 20 mM magneεium acetate, pH 7.2, 10 μl (100 μCi) 35 S-cyεteine (Amersham, Arlington Heights, IL) , 20 μl reaction buffer (Bethesda Reεearch Laboratorieε, cat. no. 8112), 40 μl rabbit reticulocyte lysate (Bethesda Research Laboratories, cat. no. 8111), 36.8 μl of water and RNA (approximately 10 μg) . The reactions were incubated at 30°C for 60 minutes, then stopped by placing on ice. Incorporation of the 35 S-cysteine was measured by precipitation with cold trichloroacetic acid (10% v/v) . Immunoprecipitation of radiolabelled chymosin polypeptides waε done by the following method: 50 μl of 35 S-labelled in vitro tranεlation reaction waε mixed with an equal volume of 2XNETS buffer (IX NETS buffer iε 150 mM NaCl, 5 mM EDTA, 50 mM Triε-HCl, pH 7.4, 0.05% Triton X-100 and 0.25% gelatin). In order to remove proteinε which non-εpecifically bind to protein A, 20 μl Panεorbin (protein A bearing Staphylococcus aureus cellε; Calbiochem, La Jolla, CA) waε added, mixed and incubated for 30 minutes at room temperature. The Pansorbin cells had previously been washed twice in IX NETS and resuspended in their original volume (10% suspension) . After incubating, the mixture was centrifuged and the supernatant was placed in a clean tube. Next 30 μl of chymosin antibody (purified by affinity chromatography and adjusted to a final concentration of 430 μg/ml in IX NETS) was added and the mixture was incubated for 2 hours at room temperature. Following incubation, 50 μl of washed Pansorbin cells were added. The suspension was mixed thoroughly and incubated for 1 hour at room temperature. Subsequently, the mixture was centrifuged and the pellet was waεhed three timeε in IX NETS. Laεtly, the pellet waε reεuεpended in 25 μl of water, mixed with an equal volume of sample buffer (1% SDS, 25 mM glycine, 192 mM Triε, pH 8.3, 50% sucroεe, 50 mM ,5-mercaptoethanol) and heated to 95°C for five minutes prior to SDS-polyacrylamide gel electrophoreεiε. Chvmoεin production bv tranεformantε 50 ml of SCM or soy medium in 250 ml shake flaskε were inoculated with fresh spore suspensions and cultured at 37 β C. Samples were assayed for chymosin protein by enzyme immunoassay "EIA" Engvall, E. (1980) Methods Enzvmol 70. 419-439 using rabbit anti-chymosin antibody and authentic calf chymoεin (Chriε Hanεenε Laboratorium, Denmark) as standard. Chymosin activity assayε were performed in microtitre plateε and were baεed on an increase in turbidity due to milk clotting. 25 μl of sample was diluted in 10 mM εodium phoεphate, pH 6.0 and 150 μl of substrate (1% skim milk, 40 mM CaCl 2 and 50 mM sodium acetate, pH 6.0) waε added. After incubation at 37"C for 15 min the turbidity waε read at 690 nm. Authentic calf chymosin was used as the standard. To determine intracellular chymosin concentrationε mycelium was harvested from 50 ml cultures, washed thoroughly with water, freeze dried and ground in a mortar and pestle with sand. 50 ml of extraction buffer (50 mM sodium phosphate pH 5.5, 0.5 M NaCl, 1 mM phenyl methyl sulfonyl fluoride, 0.1 mM pepstatin) waε added and mixed thoroughly. Sampleε of the extract were adjusted to 50 mM NaOH by the addition of 1 M NaOH, incubated at 37"C for 30 min and finally centrifuged (13,000 x g)to remove the cell debriε. Chymoεin concentration in the εupernatant was measured by EIA. For Western analysis samples were electrophoresed in SDS-polyacrylamide gels and blotted to membrane filters by standard procedures (Towbin, H. et al (1979) Proc. Natl. Accad. Sci. u.s.a. 76. 4350-4354) . Blots were sequentially treated with rabbit anti-chymosin and goat anti-rabbit IgG conjugated with horεe radiεh peroxidase (HRP) . HRP color development was then performed by incubation with H 2 0 2 and 4-chloro-l-napthol. EXAMPLE 1 Increased Chymoεin Secretion from A. awamori Construction of pGAMpR Conεtruction of the chymoεin expreεεion vectorε pGRGl and pGRG3 haε been deεcribed previouεly in Cullen, D. et al * (1987) Bio/Technology §., 369-376 and EPO Publication No. 0 215 594. They consist of an expression casεette compriεing an &. niger glaA promoter and terminator, either the glucoamylase or chymosin secretion signal, and the prochymosin B cDNA coding εequence. Thiε cassette is present in pDJB3 (Ballance, D.J. et al * (1985) Gene 36. 321-331) which consists of pBR325, the £. crassa pyr4 gene and the ansl sequence isolated from &. nidulans and conferring high transformation frequency in £. nidulanε (Fig. 3). See also FIGS. 4A through 4D which depict the caεεette inεertε used to produce pGRGl through pGRG4 respectively. The vector pGAMpR contained prochymosin B cDNA εeguences fused in frame to the last codon of the &. awamori glaA gene. Construction of this vector is outlined in Figs. 5A and 5B. Briefly, a synthetic oligonucleotide (a 54 bp Sall-BamHI fragment encoding the last ten codonε of glucoamylase and the first six codons of prochymosin) was cloned in an M13 vector and its nucleotide sequence verified. Into the same Ml3 vector we inserted a 235 bp BamHI-Asp718 fragment from pRl (Cullen (1987) supra and EPO Publication No. 0 215 594) comprising the 5' portion of the prochymosin coding sequence beginning at the seventh codon. From the resulting vector, designated M13mpl9GAM3'-5'PR, a 280 bp Sall-Asp718 fragment was isolated and used in a three-part ligation with a 2.3 kb Sall-Mlul fragment containing moεt of the &. awamori glucoamylaεe coding region pluε 0.5 kb of 5' flanking DNA and an Mlul-Aεp718 vector fragme ' nt containing a pBR322 replicon, the 3' portion of prochymosin, the glucoamylase terminator region from &. niger. and a 1.4 kb segment fXhoI-MluI) of the &. awamori glucoamylaεe promoter region. The plasmid produced from this ligation, pBR-GAMpR, waε digeεted with Clal and ligated with a 2.1 kb Clal fragment encoding the pyr4 gene from Neurospora crassa (Buxton, F.P. et al. (1983) Mol. Gen. Genet. 190. 403-405) to derive the final vector pGAMpR (Figs. 5A and 5B) . Chymosin Production Levels Protoplastε of strain GC12 and GCΔGAM23 were transformed, using PEG or electroporation, with plasmids pGRGl, pGRG3, and pGAMpR (Figs. 3, 4A, 4C, 5A and 5B) . These plasmids all included the fi. crassa pyr4 gene which is capable of complementing the pyrG mutation of &. awamori. so allowing selection of transformants. Transformants with designations beginning with the number 12 are in strain GC12, those beginning with 23 are in GCΔGAM23. The name of the plasmid used for transformation is included in the deεignation. Following purification spores from the transformantε were inoculated into 50 ml of SCM and cultured for 4 days. Replicate cultures of individual transformants were not performed and no attempt was made to correct for different growth rateε. Immunoassays were performed on the culture supernatants and on intracellular extracts of the mycelium (Table 1) . Treatment of the intracellular extract with NaOH waε required to release chymosin from the insoluble cellular debris. However, thiε treatment was also found to decreaεe the amount of detectable chymosin in standard samples using EIA by approximately 25%. Thus, the values recorded in Table 1 for intracellular chymoεin are underestimates. TABLS τ Table 1. Concentration of chymosin in samples from 4 day old SCM cultures Chymosin Concentration (μg/ml) Intra- Extra- % Intra¬ Strain cellular cellular cellular GC12 N.D. N.D. GCΔGAM23 N.D. N.D. 12grgl-l 5.4 1.2 81.8 12grgl-la 20.8 0.5 97.7 12grgl-3a 0.6 1.1 35.3 12grgl-4a 2.5 1.4 64.1 12grgl-5a 4.6 0.8 85.2 12grg3-3a 2.5 3.7 40.3 12grg3-5a 6.0 0.9 87.0 12grg3-6a 1.7 1.2 58.6 12grg3-7a 1.5 1.3 53.6 12grg3-9a 0.8 3.2 20.0 23grgl-la 4.4 1.4 75.9 23grgl-2a 20.1 0.6 97.1 23grgl-3a 4.1 0.7 85.4 23grgl-5a 5.4 0.8 87.1 23grg3-la 9.2 0.1 98.9 23grg3-2a 8.1 0.4 95.3 23grg3-3a 20.8 0.2 99.0 23grg3-6a 2.7 0.6 81.8 23grg3-7a N.D. 0.1 0.0 12gamprl 0.3 0.7 30.0 12gampr2 0.5 4.3 10.4 12gampr3 N.D. 1.2 0.0 12gampr4 2.0 33.6 5.6 12gampr31 a 0.6 26.6 2.2 12gampr58 a 0.8 24.9 3.1 23gamprl 0.3 2.0 13.0 23gampr3 N.D. 0.2 0.0 23gampr4 0.6 47.5 1.2 23garopr5 0.3 41.5 0.7 23gampr6 0.1 19.7 0.5 23gampr7 0.8 42.7 1.8 N.D. : not detected; transformantε εelected as high producers. None of the pGRGl or pGRG3 tranεformantε, expected to synthesize preprochymosin without fusion to glucoamylase, gave levels of secreted chymosin greater than 3.7 μg/ml. As noted previously using strain GC5 (see United States Patent Application Serial No. 214,237) many of the pGRGl and pGRG3 tranεformants had high intracellular levels of chymosin, with greater than 75% of the total chymosin produced remaining within the cell in many of the transformantε. In contrast, several of the pGAMpR transformantε εecreted comparatively high levelε of chymoεin and in the majority of cases the intracellular levels of chymoεin were much lower than the amountε of secreted chymosin. At this time it was noted that higher expression levels could be obtained in εoy medium, poεεibly related to the higher pH of this medium which might reduce the activity of native, secreted aspartyl proteases. Strains 12grgl-la, 12gampr4 and 23gampr46 (not shown in Table 1) were chosen as the highest producers for further study. The levels of intracellular and extracellular chymoεin produced by triplicate, 6 day old, 50 ml Soy bean meal medium cultures of these εtrains were measured by EIA and activity assays. In addition, glucoamylase concentrationε in the culture supernatants were measured by EIA (Table II) . TABLE II TABLE 2 Chymosin and glucoamylase production by transformantε expreεεed as milligrams per gram dry weight of mycelium. Extra- Intra¬ cellular Glyco- cellular Chymoεin Chymoεin amylase Chymosin Transformant Activity EIA EIA EIA 12grgl-la 1.0 1.3 64.1 0.6 12gampr4 22.0 27.7 146.0 0.0 23gampr46 14.3 21.7 59.1 0.7 In all caεeε the amount of εecreted chymoεin detected by EIA waε greater than that detected by activity aεεayε. Thiε may reflect the preεence of inactive or degraded chymoεin molecules. The resultε confirmed the high levels of secreted chymosin produced by tranεformantε expressing chymosin as a fusion protein. Approximately 140 μg of active chymosin was secreted per ml of culture by transformant 12gampr4 compared to approximately 8 μg/ml for 12grgl-la. The only glucoamylase produced by transformant 23gampr46 (deleted for the native αlaA gene) would be as part of the glucoamylaεe-chymoεin fuεion protein. Since the sizes of the two forms of glucoamylase (MW 61,000 and 71,000) are approximately twice that of chymosin (MW 37,000) one would expect double the amount, by weight, of glucoamylase to be secreted compared to chymosin. In fact, the measured ratio of glucoamylase to chymosin in the culture medium was closer to 3:1. This diεcrepancy may be due to inaccuracieε in the assays or may indicate that degradation of chymosin haε occurred. In tranεformant 12grgl-la only native glucoamylaεe would be produced whereaε in 12gampr4 both native and chymoεin-aεεociated glucoamylase would be secreted. Interestingly, almost as much recombinant glucoamylaεe was produced in 23gampr46 as native glucoamylaεe in 12grgl-la. Although a high percentage (32%) of the total amount of chymoεin produced by 12grgl-la remained within the cell thiε waε not nearly as dramatic as the intracellular accumulation observed in SCM culture. Southern Blot Analysiε DNA waε extracted from strains GC12 and GCΔGAM23 and from transformantε 12gampr2, 12gampr3, 12gampr4, 23gamprl and 23gampr46, digeεted with ffhol and Hindlll. and εubjected to electrophoreεiε. After blotting onto membrane filterε the DNA waε hybridized with radiolabelled pGAMpR (Fig.8). For strain GC12 a single band repreεenting the native glaA gene waε obεerved (Fig. 8, Lane a). A smaller sized glaA fragment was seen in strain GCΔGAM23 due to the gene replacement event at this locuε (Fig. 8, Lane e) . The plaεmid pGAMpR waε alεo run on the gel to show the size of fragments obtained from thiε on digeεtion with Xhol and Hindlll (Fig. 8, Lane h) . Additional bandε derived from pGAMpR were observed in the transformantε. For 12gampr4 and 23gamprl the pattern waε conεiεtent with the integration of a few tandem copieε of pGAMpR at a single site away from the glaA locus (Fig. 8, lanes d and f) . The number of plaεmid copieε in theεe tranεformantε appears to be similar despite the large differences in chymosin productivity. Although tandem plaεmid integration haε probably occurred more extensive plasmid rearrangementε were alεo involved in tranεformantε 12gampr2, 12gampr3 and 2 gampr46 (Fig. 8, lanes b, c and g) . Northern Analysis Total RNA was extracted from strains GC12, 12grgl-la and 12gampr4 subjected to electrophoresis and blotted to membrane filterε. The RNA waε then hybridized εimultaneouεly with two radiolabelled DNA probeε (Fig. 9) . One of theεe probeε was a 5kb EcoRl fragment containing the __. niger olic gene (Ward et al (1988) Curr. Genet. _±, 37-42) to act as " an internal control demonεtrating that equivalent amountε of the different RNA samples were applied to the gel and that none of the εampleε waε exceεεively degraded. The second probe was an approximately 850 bp Kpnl - Bell fragment of chymosin coding εequence. In addition to the olic mRNA band of approximately lkb a 1.4 kb band representing chymoεin mRNA waε obεerved in tranεformant 12grgl-la (Fig. 9, lane b) . It was apparent that abundant chymosin-specific mesεage waε preεent in thiε transformant although the level of chymosin production was very much lower than glucoamylase production (this strain is capable of secreting approximately 0.8 gm/1 of glucoamylase). A mRNA species of the size expected for a fused glucoamylase-chymoεin message (3.4 kb) waε obεerved in strain 12gampr4 (Fig. 9 , lane c) . This fused mRNA species appeared to be lesε abundant than the chymosin-specific mRNA present in transformant 12grgl-la even though chymosin production was much greater in transformant 12gampr4. Only the olic mRNA waε obεerved in εtrain GC12 (Fig. 9, lane a) . In vitro translation Polyadenylated RNA samples isolated from cultureε of transformants 12gampr4, 23gamp46 and 12grgl-la were translated in a commercial rabbit reticulocyte in vitro translation system. Chymosin was immuno- precipitated from the translation productε, -subjected to SDS-polyacrylamide gel electrophoreεiε and visualized by autoradiography (Fig. 10) . Two distinct bands, representing proteins of MW 37,000 and 42,000, were observed with mRNA from 12grgl-la (Fig. 10, lane b) which was expected to produce only preprochymosin (MW 42,000). The lower MW εpecies may represent mature chymosin although autocatalytic processing would not be expected to take place at the pH at which the translation reactions were performed. With 12gampr4 (Fig. 10, lane a) and 23gampr46 mRNA sampleε two high MW εpecies were precipitated with the anti-chymosin antibody. Theεe were of the approximate size expected for full-length fusion proteinε (100,000 and 110,000 MW) containing prochymoεin and either one or the other of the two forms of glucoamylase. No chymosin could be immunoprecipitated if GC12 RNA (Fig. 10, lane c) or no RNA (Fig. 10, lane d) was added to the in vitro translation system. Western analysiε Supernatants were collected from 50 ml SCM or soy medium cultures of tranεformantε 12gampr4, 23gampr46 and 12grgl-la at variouε time pointε after inoculation. Sampleε were separated by SDS- polyacrylamide gel electrophoresiε, blotted to membrane filterε and probed with antibody specific for chymosin (Fig. 11) . No chymosin was observed in the culture supernatant from strain GC12 (Fig. 11, lane b) . Authentic bovine chymosin was also run on the gel (Fig. 11, lanes a and i) . A band of the same size as authentic bovine chymosin (37,000 MW) was observed in all the samples from SCM cultures of 2 days and older. In soy medium cultures of 12gampr4 (Fig. 11, lane g) and 23gampr46 an additional band of approximately the εize expected (100,000 MW) for a full-length glucoamylaεe-chymoεin fuεion protein waε evident at 2 and 3 dayε although thiε waε diminiεhed at later time pointε. The major chymosin-specific band present in sampleε from 12grgl-la cultureε in εoy medium at 2 days was of the size predicted for prochymosin (Fig. 11, lane d) . Soy roedum waε buffered at pH6.2, whereas SCM medium was at pH 5. At the higher pH activation of prochymosin would be expected to be slow. The pH of sampleε from day 2 or 3 εoy medium cultureε waε lowered to pH2 for 30 min. at room temperature. The pH waε then raiεed immediately to above pH 6 before loading the sample onto an SDS polyacrylamide gel for Western analysis. This treatment led to a loss of the large molecular weight band from 12gampr4 (Fig. 11, lane h) or 23gampr46 or loss of prochymosin from 12grgl-la (Fig. 11, lane e) and the accumulation of a protein species slightly larger than mature chymosin, possibly pseudochymosin in all transformantε. Theεe changes in the size of chymosin-specific bands were inhibited if the aspartyl proteaεe inhibitor pepstatin (Marciniszyn, J. Jr. et al * (1976) J. Biol. Chem. 251. 7095-7102) was included at 0.1 mM during the low pH treatment. Chymosin concentration measured by activity asεayε on samples from 2 day old soy medium cultures of 12grgl-la and 23gampr46 were 0.7 and 3.2 μg/ml respectively before treatment at pH 2. Following treatment these values rose to 3.6 and 17.5 μg/ml reεpectively, an increase of approximately 5 fold in each case. As can be seen from Tables I and II, the yields of εecreted chymoεin in A_. awamori are greatly enhanced if prochymoεin iε εyntheεized as a fusion with the carboxyl terminuε of glucoamylaεe aε compared to direct expreεεion from the glaA promoter utilizing the glucoamylaεe εignal peptide. Increased efficiency of secretion of the fusion protein compared to prochymosin appears to be at least part of the explanation for higher expression levels. Thiε iε apparent from the high proportion of chymosin found within the cell in pGRGl and pGRG3 transformantε compared to pGAMpR tranεformantε. Neither authentic bovine chymoεin, nor the majority of the chymosin produced in A_. awamori are glycosylated. Attachment of prochymoεin to glucoamylaεe, which iε extenεively decorated with 0-1inked carbohydrates in A_. niger (Pazur, J.H. §t al * (1987) J. Protein Chem. 6 , 517- 527) , may allow more efficient passage through the Aspergilluε secretory pathway. The plasmidε pGRGl and pGRG3 both employ an .. niger glaA promoter to direct chymosin expression, whereas an A. awamori glaA promoter iε preεent in pGAMpR. There are additional differenceε between these plasmids such as the incluεion of the anεl sequence on pGRGl and pGRG3. Integration of the various plasmids was probably not by homology with the native glaA locus. Consequently, the chromosomal location of the integrated plaεmidε waε presumably different in each transformant. All of these differences make it difficult to compare the total amounts of chymosin produced (intracellular plus extracellular) and to determine if thiε iε similar between transformants, with the distribution between the inεide and the outεide of the cell being the only diεtinction between direct expreεsion and production as a fusion protein. Northern analysis suggested that the steady state level of chymoεin-εpecific mRNA were higher in tranεformant 12grgl-la than in 12gampr4, making εome comparison of chymosin yieldε valid. Analyεiε of the total amount of chymosin produced by transformantε 12grgl-la, 12gampr4 and 23gampr46 in soy medium showed that the total amount of chymosin produced in the direct expresεion tranεformant waε much leεε than that in the transformants expresεing chymoεin as a fusion protein. This might suggeεt that enhanced efficiency of secretion may not be the only benefit of expression of chymosin fused to glucoamylase. It is possible that translation of the glucoamylase-chymosin fusion mRNA was more efficient than translation of prochymosin mRNA in which only the untranslated leader sequence and the secretion εignal εequence was derived from the αlaA gene. However, it may be difficult to get an accurate value for intracellular chymosin levels since extraction may not be complete and the NaOH treatment required to release chymoεin reduced detection by EIA. Additionally, chymoεin which accumulateε intra¬ cellularly may be subject to degradation by native proteaseε prior to extraction. Conεequently, the figures obtained for intracellular chymosin concentrations will always be underestimates. It was apparent, using samples from young cultures in soy bean meal medium at pH 6, that a large proportion of the glucoamylase-prochymosin fusion protein was secreted to the medium intact, ^although some mature chymoεin was also obεerved. Under theεe conditions prochymoεin waε the only form detected by Weεtern analyεis of sampleε from the direct expreεεion tranεformant 12grgl-la. In contraεt, only mature chymoεin waε detected in cultureε of any of the tranεformantε in SCM at pH 5. Theεe observations suggested that the release of chymoεin from the glucoamylaεe-chymoεin fuεion protein was favored at low pH and may involve the natural autocatalytic activation mechanism of prochymosin. Loss of the fusion protein and an increase in active chymoεin concentration could be induced simply by lowering the pH of εa pleε to 2. Aε might be expected if processing was dependent on chymosin activity, at least some of the chymosin released from the fusion protein under theεe conditions appeared to be in the form of pseudochymosin. Presumably, thiε would eventually be further processed to mature chymosin under the appropriate conditions. Procesεing of the fuεion protein at pH 2 waε inhibited by pepstatin suggesting that it required the activity of an aspartyl protease. This activity could be supplied by chymoεin itεelf or by a native &. awamori proteaεe. We have constructed a strain of A. awamori in which the gene encoding the major secreted aspartyl protease, aspergillopepsin-A, has been deleted (see U. S. Patent Application Serial No. 214,237). Although there iε a low level of extracellular proteolytic activity remaining in this strain, this activity is unaffected by pepstatin. Procesεing of the glucoamylase-chymosin fusion in this aspergillopepsin-deleted strain is indistinguishable from the processing described above for transformants 12gampr4 and 23gampr46 (data not shown) . This iε further indication that the pepstatin-inhibitable activity which causeε processing of the fusion protein iε actually that of chymoεin itεelf. Amino terminal εequencing of the mature chymoεin obtained from pGAMpR tranεformants has confirmed that correct proceεsing has occurred (resultε not shown) . Other tests, including amino acid composition analysis, specific activity determination, Ouchterlony plate tests and cheese-making trials , have confirmed the authenticity of the chymosin produced in these transformants. EXAMPLE 2 Secretion of Chymosin from a Fuεion Polypeptide Containing A. awamori α-amylaεe Conεtruction of pAMpRI and pAMpRII Aspergillus awamori strain UVK143f has two almost identical α-amylase geneε (amyA and amvB) , both of which had been cloned and one of which haε been sequenced (Korman, D. R. , (1988). The cloning and characterization of α-amylase genes of Aεpergilluε orvzae and Aεpergilluε awamori. MA thesis, San Fransisco State University) . Subsequently, the εecond gene has been εequenced. The amvA gene encodes a protein of 496 amino acids including an amino terminal signal sequence of 21 amino acids. The sequence for each of the two genes is identical, including 200 bp of sequence 5' to the translation start codon, the position and sequence of the eight introns and the entire coding sequence except for the sequence encoding the final two or three carboxyl terminal amino acids (codons for tyroεine and glycine in amvA are replaced by three serine codons in amyB) . The vectors pUCAMpRI and pUCAMpRII contain similar prochymosin B expreεεion cassettes to pGAMpR except that the promoter, the entire coding εequence of the A. awamori amvA or amyB geneε and the amvA terminator and polyadenylation εequence replace thoεe of the glaA gene. Construction of pUCAMpRI is described in Fig. 6. Briefly, a εynthetic oligonucleotide encoding the laεt five amino acidε of α-amylaεe fa yA version) and the first six amino acids of prochymoεin waε uεed to link exactly and in frame a BamHI-Aεp718 fragment encoding a region of the prochymoεin B coding sequence starting at the seventh codon with a Bglll-Hindlll fragment encoding the promoter region (up to 617 bp 5' of the translation start codon) and all of the coding sequence of amvA up to the sixth codon prior to the translation stop codon (pUCAMYint. #2). The remaining portion of the chymosin coding sequence was added as an Asp718-Xbal fragment taken from a GRG1 type expreεεion caεεette to give pUCAMYint. #3 (i.e., the Xbal εite 11 bp after the tranεlation εtop codon being an engineered εite introduced during conεtruction of pGRGl) . Site directed mutageneεis was used to introduce an Xbal site 11 bp after the tranεlation stop codon of the amvA gene so that the terminator and polyadenylation region (581 bp) from this gene could be placed immediately after the prochymoεin sequence in pUCAMYint. #3 to give pUCAMpRI. The vector pUCAMpRII was essentially the same except that the aroyA promoter was exchanged for the corresponding region of the amyB gene. Secretion of Chvmosin The plasmids pUCAMpRI and pUCAMpRII contain no gene which could be used as a selectable marker for transformation into filamentouε fungi. It was therefore necessary to introduce these plaεmidε into A., awamori by cotranεformation with a second plasmid which did contain a selectable marker. Consequently approximately 10μg of pUCAMpRI or pUCAMpRII waε mixed with approximately 2μg of pBH2 (pUClδ with a 2.4 kb Ba HI-Hindlll fragment containing the Aεpergillus niger pyrG gene) and used to tranεform εtrain ΔAP3 (deεcribed in United Stateε Patent Application Serial No. 214,237) uεing complementation of the pyrG mutation in thiε εtrain aε a εelection εyεte for transformants. A proportion of the transformants obtained in this manner should contain both plasmidε. Individual transformants were subsequently grown in 1 ml liquid cultures in 24 well microtiter plates and the culture supernatants assayed for chymosin activity. Those transformants which produced the greatest amount of active, secreted chymosin were then grown in 50 ml shake flask cultures in εoy bean meal medium for further analysiε. The greatest amount of chymosin produced by transformants of εtrain ΔAP3 waε similar regardlesε of whether pUCAMpRI or pUCAMpRII waε uεed for tranεformation. The maximum production obεerved waε 70-80μg/ml of chymoεin. Thiε iε higher than the level of production expected if the preprochymoεin had been fuεed directly to the α- amylase promoter without incluεion of the α-amylase coding εequence. Western immunoblotting analyεiε of culture supernatantε using anti-chymosin antibodieε for specific staining showed that, as with pGAMpR transformantε, a fusion protein could be observed in addition to a band the εize- of mature chymosin (37,000 MW) . The fusion protein waε of the expected εize (91,000 MW) for a full length α-amylaεe/pro- chymosin fusion polypeptide and could also be identified using anti-α-amylase antibody for specific staining. Mature chymosin waε releaεed from the Q-amylase/prochymosin fuεion protein at low pH aε was observed for the glucoamylase/prochymoεin fuεion protein. EXAMPLE 3 Construction of pSGl In order to test if enhanced chymosin production and secretion could be achieved by fusing a εmaller part of the glucoamylase polypeptide sequence to the amino terminus of prochymosin a vector, pSGl, was constructed (Fig. 7) . The starting point for thiε plasmid construction was a vector (pUCAagrg4) containing a Xhol/Hindlll glucoamylaεe/chymoεin expreεεion caεεette (promoter, coding sequence and terminator regions) identical to that in pGRG4 (εee EPO Publication No. 0 215 594) except that the Aspergillus awamori UVK143f glaA promoter, signal sequence, prosequence and first 11 codons of the mature coding sequence replaced the equivalent region from the &. niαer αlaA gene. Thiε expreεεion caεεette was inserted between the Hindlll and Sail siteε of pUC18 (Yaniεch-Peron, at. al * • 1985, Gene 33. 103-119). From pUCAagrg4 we isolated a 2.3 kb Asp718 fragment containing the __. awamori UVK143f αlaA promoter, signal sequence, prosequence and first 11 codons of the mature glucoamylase coding sequence as well as an amino terminal portion of the prochymosin coding εequence. This fragment was cloned into the Asp718 restriction site of pUC18 to give pUCgrg4X/K. A 1 kb BssHII fragment from the coding sequence (from within the proεeguence to a point approximately half way through the mature coding sequence) of the &. awamori glaA gene was inserted into the unique BssHII site in the αlaA prosequence region of pUCgrg4X/K to give pUCgrg4X/K+B. Finally, we isolated the larger Asp718 fragment from pUCAagrg4, containing the pUC replicon, the 3 ' end of the chymosin coding .εequence and the A. niger glaA polyadenylation and termination region and ligated thiε with the larger Asp718 fragment from pUCgrg4X/K+B to give pSGl. The glucoamylase/prochymoεin polypeptide expected to be produced aε a result of transcription and translation should consiεt of glucoamylaεe εignal εequence, glucoamylaεe prosequence, amino acids 1-297 of mature glucoamylase followed immediately by amino acids 1-11 of mature glucoamylase and finally prochymoεin at the carboxyl terminuε. We have uεed pSGl in cotransformation experimentε with pBH2 but have failed to identify tranεformantε which produce active chymosin. The reason for this iε unclear and further work is in progresε to clarify the εituation. It may be that the glucoamylase/pro- chymosin fusion polypeptide encoded by this plasmid is not secreted efficiently, or mature, active chymosin may not be released from the fusion polypeptide. However, it is also conceivable that the plasmid was not constructed as predicted, or that transcription or translation of the gluco- amylaεe/chymoεin coding sequences were not efficient. The foregoing are presented by way of example only and should not be construed as a limitation to the scope of permissible claims. Having deεcribed the preferred embodimentε of the preεent invention, it would appear to those ordinarily skilled in the art that various modificationε may be made to the disclosed embodiments, and that εuch modificationε are intended to be within the εcope of the preεent invention. All referenceε are expressly incorporated herein by reference.

Claims: WHAT IS CLAIMED IS: 1. A fuεion DNA εequence encoding a fuεion polypeptide compriεing, from the 5' end of εaid fusion DNA sequence, first, second, third and fourth DNA sequences encoding, from the amino- to caboxy- terminuε of said fusion polypeptide, corresponding first, second, third and fourth amino acid sequences, said firεt DNA εequence encoding a εignal peptide functional aε a εecretory sequence in a first filamentous fungus, said second DNA sequence encoding a secreted polypeptide or portion thereof normally εecreted from said first or a second filamentous funguε, εaid third DNA sequence encoding a cleavable linker polypeptide and said fourth DNA sequence encoding a desired polypeptide, wherein the expresεion of εaid fuεion DNA εequence in said first or εaid εecond filamentouε funguε results in increased secretion of said desired polypeptide as compared to the εecretion of εaid desired polypeptide from said first or said second filamentous fungus when expressed aε a second fusion polypeptide encoded by a second fuεion DNA εequence compriεing only εaid first, third and fourth DNA sequences. 2. The fusion DNA sequence of Claim 1 wherein said firεt DNA εequence encodes a signal peptide or portion thereof εelected from the group conεiεting of εignal peptides from glucoamylase, α-amylase, and aspartyl protease from Aspergilluε species. signal peptides from bovine chymosin and human tissue plasminogen activator and εignal peptides from Trichoderma cellobiohydrolaεe I and II. 3. The fusion DNA sequence of Claim 1 wherein εaid firεt DNA sequence encodes the signal peptide from Aspergillus awamori glucoamylase. 4. The fuεion DNA εequence of Claim 1 wherein εaid second DNA sequence encodes a secreted polypeptide selected from the group consisting of glucoamylase, α-amylase, and aspartyl protease from Aspergilluε εpecies and Trichoderma cellobiohydrolase I and II. 5. The fusion DNA sequence of Claim 1 wherein said second DNA sequence encodes glucoamylase from Aspergillus awamori. 6. The fusion DNA sequence of Claim 1 wherein said third DNA sequence encodeε a cleavable linker polypeptide εelected from the group consisting of the prosequence from chymosin, the prosequence of εubtiliεin, and εequenceε recognized by trypεin factort X a , collagenase, clostripain, εubtiliεin and chymosin. 7. The DNA sequence of Claim 1 wherein said third DNA εequence encodeε the proεequence of chymoεin or a portion thereof. 8. The fuεion DNA sequence of Claim 1 wherein said fourth DNA sequence encodes a desired polypeptide εelected from the group consisting of enzymes, proteinaceous hormones and serum proteins. 9. The fusion DNA εeguence of Claim 1 wherein εaid fourth DNA sequence encodes bovine chymoεin. 10. The fusion DNA sequence of Claim 1 wherein εaid first DNA sequence encodes the signal peptide from Asperoilluε awamori glucoamylase, said second εequence encodeε glucoamylaεe from Aspergillus awamori said third sequence encodes the prosequence of chymosin and said fourth sequence encodes chymosin. 11. An expression vector for transforming a host filamentous fungus comprising DNA sequences encoding regulatory sequences functionally recognized by said host filamentous fungus including promoter and transcription and translation initiation sequences operably linked to the 5' end of the fusion DNA sequence of Claim 1 and transcription stop sequences and polyadenylation sequences operably linked to the 3' end of said fuεion DNA εequence. 12. The expreεεion vector of Claim 11 wherein εaid first and said εecond DNA εequences encoding respectively said signal peptide and εaid εecreted polypeptide are selected from filamentous fungi of the same genus aε said host filamentous fungus. 13. The expreεsion vector of Claim 11 wherein said genus is εelected from the group conεiεting of Aspergillus. Trichoderma. Neurospora. Penicillium. Cephalosporium. Podoεpora . Endothia . Mucor. Cochlioboluε. Pyricularia. Achlya and Humicola. 14. The expreεεion vector of Claim 13 wherein εaid genus is Aspergilluε. 15. The expresεion vector of Claim 11 wherein εaid firεt and said εecond DNA εequences encoding reεpectively εaid εignal peptide and said εecreted polypeptide are from εaid host filamentous fungus. 16. A filamentous funguε containing an expreεεion vector selected from the group of the expression vectors of Claims 11 through 15. 17. A fusion polypeptide compriεing, from the amino-to caboxy-terminus, firεt, second, third and fourth amino acid sequences, εaid firεt amino acid εequence compriεing a εignal peptide functional as a secretory sequence in a first filamentous fungus, said second amino acid sequence comprising a secreted polypeptide or portion thereof normally εecreted from said first or a second filamentous fungus, said third amino acid sequence comprising a cleavable linker polypeptide and said fourth amino acid sequence comprising a desired polypeptide, wherein the expression of the fusion DNA sequence encoding said fusion polypeptide in said first or said second filamentous fungus results in increased εecretion of said desired polypeptide as compared to the secretion of said desired polypeptide from said first or said second filamentous funguε when expreεεed from a second fusion DNA sequence encoding a εecond fusion polypeptide comprising εaid first, third and fourth amino acid sequences. 18. The fusion polypeptide of Claim 17 wherein said first amino acid sequence comprises a εignal peptide or portion thereof εelected from the group consisting of signal peptides from glucoamylase, α-amylaεe, and aspartyl proteaεe from Aspergillus species, signal peptides from bovine chymosin and human tisεue plaεminogen activator and εignal peptides from Trichoderma cellobiohydrolase I and II. 19. The fusion polypeptide of Claim 17 wherein said first amino acid εequence is the signal peptide from Aspergillus awamori glucoamylase. 20. The fusion polypeptide of Claim 17 wherein said second amino acid sequence iε selected from the group consiεting of glucoamylaεe, α-amylaεe, and aspartyl protease from Aspergillus species and Trichoderma cellobiohydrolase I and II. 21. The fusion polypeptide of Claim 17 wherein said εecond amino acid εequence iε glucoamylaεe from Aspergillus awamori. 22. The fusion polypeptide of Claim 17 wherein said cleavable linker polypeptide is selected from the group consisting of the prosequence of subtilisin, and sequences recognized by trypsin factorxa, collagenase, cloεtripain, subtilisin and chymosin. 23. The fusion polypeptide of Claim 17 wherein said third amino acid εequence iε the proεequence of chymoεin. 24. The fuεion polypeptide of Claim 17 wherein εaid fourth amino acid εequence is selected from the group consisting of enzymes, proteinaceous hormoneε and εerum proteins. 25. The fusion polypeptide of Claim 17 wherein said fourth amino acid sequence is chymosin. 26. The fusion polypeptide of Claim 17 wherein said firεt amino acid εequence is the signal peptide of A. awamori glucoamylase, said third amino acid sequence is the prosequence of chymosin and said fourth amino acid sequence is bovine chymoεin. 27. A process for producing a desired polypeptide comprising: tranεforming a hoεt filamentouε fungus with an expression vector containing the fusion DNA sequence of Claim 1 under conditions which permit expresεion of said fusion DNA sequence to cause the secretion of the deεired polypeptide encoded by εaid fusion DNA εequence.

Inventors: LAWLIS VIRGIL BRYAN, LAWLIS, VIRGIL, BRYAN
Applicants: GENENCOR INC, GENENCOR, INC.
Application year: 1990
Main classification: C12N1
IPC codes: A61K38, C07H21, C07K14, C07K19, C12N1, C12N9, C12N15, C12P21, C12R1